Targeting of CD122 enhances antitumor immunity by altering the tumor immune environment

Keyphrases

• Monoclonal Antibody 100%
• Tumor Immunity 100%
• CD122 100%
• Tumor Immune Environment 100%
• Tumor Growth 66%
• Cancer Immunotherapy 66%
• Tumor 33%
• Vaccine Response 33%
• Long-term Survival 33%
• T Cell Response 33%
• CD8+ T Cells 33%
• Promising Target 33%
• Therapeutic Effect 33%
• Memory T Cells 33%
• Cytolytic 33%
• Myeloid-derived Suppressor Cells 33%
• Tumor-bearing Mice 33%
• Antigen-specific CD8+ T Cells 33%
• CD8+CD122+ T Cells 33%
• Polyfunctional 33%
• Anti-GITR 33%

Immunology and Microbiology

• Monoclonal Antibody 100%
• Immunity 100%
• T Cell 66%
• Cytotoxic T-Cell 66%
• Cancer Immunotherapy 66%
• Immunotherapy 33%
• Antigen Specificity 33%
• CD8 33%
• Long Term Survival 33%
• Memory T Cell 33%
• Myeloid-Derived Suppressor Cell 33%